Lifestyle modifies the relationship between body composition and adrenergic receptor genetic polymorphisms, ADRB2, ADRB3 and ADRA2B: a secondary analysis of a randomized controlled trial of physical activity among postmenopausal women.
Genetic variations in the adrenergic receptor (ADR) have been associated with body composition in cross-sectional studies. Recent findings suggest that ADR variants may also modify body composition response to lifestyle. We assessed the role of ADR variants in body composition response to 12 months of resistance training versus control in previously sedentary postmenopausal women. Randomized trial completers were genotyped for A2B (Glu9/12) by fragment length analysis, and B2 (Gln27Glu) and B3 (Trp64Arg) by TaqMan (n = 148, 54% hormone therapy users). Associations between genotypes and body composition, by dual energy X-ray absorptiometry, were analyzed using univariate models. There was no main effect of individual genes on change in body composition, however, gene x exercise interactions were observed for A2B (Glu9/12) and B2 (Gln27Glu) on change in lean soft tissue (LST, p = 0.02); exercisers on the A2B (Glu9-) background gained LST compared to a loss among controls over 12 months (p < 0.05), with no significant intervention effect on the A2B (Glu9+) background. Similarly, there was a significant LST gain with exercise on the B2 (Glu27+) background compared to loss among controls and no intervention effect on the B2 (Glu27-) background. A non-significant association between total body fat (TBF) and B3 (Trp64Arg) persisted among sedentary controls only when intervention groups were separated (%TBF gain with B3 (Arg64+) carriage, p = 0.03); exercisers lost TBF regardless of genotype. In summary, effect modification by lifestyle was demonstrated on ADRA2B, B2, and B3 genetic backgrounds. Individuals with certain ADR genotypes may be more vulnerable to adverse changes in body composition with sedentary behavior, thus these candidate genes warrant further study.
Bea
Jennifer W
JW
Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA. jbea@azcc.arizona.edu
Lohman
Timothy G
TG
Cussler
Ellen C
EC
Going
Scott B
SB
Thompson
Patricia A
PA
D000483:Alleles; D001823:Body Composition / Q000235:genetics*; D015444:Exercise / Q000502:physiology; D005260:Female; D005838:Genotype; D006801:Humans; D008875:Middle Aged; D011110:Polymorphism, Genetic / Q000235:genetics*; D017698:Postmenopause / Q000502:physiology; D018341:Receptors, Adrenergic, alpha-2 / Q000235:genetics*; D018343:Receptors, Adrenergic, beta-2 / Q000235:genetics*; D022702:Receptors, Adrenergic, beta-3 / Q000235:genetics*
C547771:ADRA2B protein, human; D018341:Receptors, Adrenergic, alpha-2; D018343:Receptors, Adrenergic, beta-2; D022702:Receptors, Adrenergic, beta-3
N Engl J Med. 1995 Aug 10;333(6):382-3
7609759
Eur J Appl Physiol Occup Physiol. 1981;46(4):339-45
6266825
Obes Res. 2001 Jun;9(6):337-41
11399779
Annu Rev Pharmacol Toxicol. 2003;43:381-411
12540746
Int J Obes Relat Metab Disord. 1998 Jun;22(6):559-66
9665677
Diabetes. 1999 Jan;48(1):117-20
9892231
Obesity (Silver Spring). 2008 Dec;16 Suppl 3:S5-S10
19037213
Eur J Appl Physiol Occup Physiol. 1990;60(6):418-24
2167842
Med Sci Sports Exerc. 2003 Apr;35(4):555-62
12673136
Int J Obes Relat Metab Disord. 2002 Nov;26(11):1434-41
12439644
Obesity (Silver Spring). 2008 Dec;16 Suppl 3:S11-22
19190620
Int J Obes Relat Metab Disord. 2001 Nov;25(11):1609-14
11753579
Osteoporos Int. 2003 Aug;14(8):637-43
12844212
Lancet. 1999 Mar 13;353(9156):896
10093985
Int J Obes (Lond). 2009 Jan;33(1):29-36
19048013
J Physiol. 2002 Sep 1;543(Pt 2):399-411
12205177
Pharmacol Rev. 2004 Mar;56(1):31-52
15001662
Naunyn Schmiedebergs Arch Pharmacol. 1994 Jan;349(1):34-41
7908124
Med Sci Sports Exerc. 2005 Jun;37(6):881-903
15947712
Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):687-96
11401920
Am J Clin Nutr. 2009 Apr;89(4):1011-8
19225119
J Clin Endocrinol Metab. 1999 Jul;84(7):2429-33
10404816
Mol Endocrinol. 2004 Sep;18(9):2123-31
15243132
J Clin Invest. 1993 Jan;91(1):344-9
8380813
Chin Med J (Engl). 2005 Nov 5;118(21):1797-802
16336817
Obes Res. 2003 May;11(5):612-8
12740450
Obes Res. 2004 May;12(5):807-15
15166301
J Gerontol A Biol Sci Med Sci. 2007 Jun;62(6):658-63
17595424
J Biol Chem. 2001 Feb 16;276(7):4917-22
11056163
Eur J Biochem. 1997 Aug 1;247(3):1174-9
9288945
Diabetes Obes Metab. 2002 Nov;4(6):428-30
12406043
Diabetes. 1999 Jan;48(1):203-5
9892244
J Hypertens. 2005 Dec;23(12):2201-7
16269962
Obesity (Silver Spring). 2006 Apr;14(4):529-644
16741264
J Appl Physiol (1985). 2004 Feb;96(2):526-30
14715679
Diabetes. 2001 Jan;50(1):91-5
11147800
Osteoporos Int. 2005 Dec;16(12):2129-41
16283062
Circ Res. 2000 Apr 28;86(8):834-40
10785504
Endocr Rev. 1993 Feb;14(1):72-93
8491156
J Intern Med. 1999 Jun;245(6):667-72
10395196
Am J Clin Nutr. 1995 Feb;61(2):274-8
7840063
Am J Physiol. 1998 Dec;275(6):E909-16
9843731
Nat Rev Genet. 2009 Apr;10(4):241-51
19293820
Trends Pharmacol Sci. 2001 Sep;22(9):471-7
11543875
Obesity (Silver Spring). 2008 Dec;16 Suppl 3:S95-6
19037222
Pharmacol Ther. 2008 Jan;117(1):1-29
17916379
Med Sci Sports Exerc. 2004 Sep;36(9):1451-69
15354024
J Nutr Biochem. 2003 May;14(5):275-9
12832031